Health Professionals > LDI Drug Formulary & Changes>DRUG NEWS
Current Drug Information & News
Welcome to LDI Drug Info & News! Here you will find links to important industry news, including drug safety advisories, recalls and withdrawls from the market, FDA drug approvals, first time generic drugs and more.
October
- 10/28/10 FDA approves Latuda to treat schizophrenia in adults
- 10/28/10 FDA approves additional medical indication for Sprycel
- 10/21/10 New Label Changes for Commonly Prescribed HIV Drug Invirase
- 10/20/10 FDA: Include warnings on risk for class of prostate cancer drugs
- 10/19/10 FDA approves Pradaxa to prevent stroke in people with atrial fibrillation
- 10/15/10 FDA approves Botox to treat chronic migraine
- 10/14/10 FDA issues warnings to marketers of unapproved ‘chelation’ products
- 10/13/10 FDA Press Release: Risk of Thigh Bone Fracture with Bisphosphonates
- 10/12/10 FDA approves injectable drug to treat opioid-dependent patients
- 10/04/10 FDA awards nearly $3 million for TB research
September
- 09/30/10 FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine
- 09/28/10 FDA issues final rule on safety information during clinical trials
- 09/24/10 FDA approves combination contraceptive containing a folate
- 09/22/10 FDA approves first oral drug to reduce MS relapses
- 09/23/10 FDA significantly restricts access to the diabetes drug Avandia
- 09/22/10 FDA approves first oral drug to reduce MS relapses
- 09/17/10 FDA reviewing preliminary safety information on Actos (pioglitazone)
July
- 07/23/10 FDA Approves First Generic for Lovenox (enoxaparin) Sodium Injection
- 07/21/10 FDA Statement on Avandia TIDE Trial
- 07/15/10 FDA Ongoing Safety Review of ARBs and Risk of Cancer
- 07/13/10 Arava (leflunomide) Boxed Warning
- 07/06/10 FDA Approves Zuplenz (ondansetron) Oral Soluable Film
- 07/01/10 FDA Approves Butrans Transdermal System for Pain Management
- 07/01/10 FDA Approves Glassia for Emphysema
June
- 06/30/10 First Generic for Differin (adapalene) Cream is Approved
- 06/22/10 FDA Approves Combination Inhaler Dulera for Asthma
- 06/01/10 FDA Approves Prolia Injection for Osteoporosis
May
- 05/26/10 Safety Concerns with Weight Loss Drugs
- 05/25/10 First Phase III Trial with Telaprevir Shows Promise for Treating Hepatitis C
- 05/25/10 FDA Approves Lumizyme for Pompe Disease
- 05/25/10 Safety Update on Proton Pump Inhibitors
- 05/17/10 Sagent Pharmaceuticals Recalls Metronidazole Injection
- 05/12/10 Promacta (eltrombopag) Safety Update
- 05/06/10 FDA Approves 1st 4-phasic Combination Oral Contraceptive Marketed in U.S.
- 05/03/10 GnRH Agonists: FDA Safety Review for Drugs Used to Treat Prostate Cancer
April
- 04/30/10 Vimovo Approved by the FDA to Treat Signs and Symptoms of Arthritis
- 04/30/10 McNeil Consumer Hlth Care Recalls Infant and Children's OTC Products
- 04/29/10 FDA Approves Provenge for Treatment of Advanced Prostate Cancer
- 04/07/10 Generic Versions of Cozaar and Hyzaar Approved by FDA
- 04/05/10 FDA Approves New Formulation of OxyContin
March
- 03/30/10 FDA Approves Asclera to Treat Small Varicose Veins
- 03/19/10 Zocor (simvastatin) Safety Update
- 03/18/10 FDA Approves Carbaglu to Treat Condition Causing Elevated Ammonia
- 03/12/10 Plavix (clopidogrel) Gets Boxed Warning from FDA
- 03/09/10 FDA Approves New Indications for Botox
- 03/04/10 FDA Approves Hizentra for Treatment of Primary Immunodeficiency
- 03/04/10 FDA Approves Name Change for Heartburn Drug from Kapidex to Dexilant
- 03/02/10 FDA Approves First Time Generic Tamsulosin, Generic version of Flomax
February
- 02/26/10 FDA Approves VPRIV to Treat Gaucher Disease
- 02/23/10 Invirase (saquinavir) Ongoing Safety Review of Data
- 02/22/10 Avandia (rosiglitazone) Ongoing Review of Cardiovascular Safety
- 02/18/10 FDA Announces REMS program for Long Acting Beta Agonists
- 02/16/10 FDA Announces REMS program for Erythropoiesis-Stimulating Agents
